ibrutinib), and the B-cell lymphoma (BCL)-2 inhibitor venetoclax. 48 These suggestions were further substantiated by an evaluation of duvelisib in combination with dexamethasone, ibrutinib ...

Two decades ago, a link between apoptosis and cancer was recognized, following the discovery that the protein BCL-2 specifically blocked apoptotic death of B cells in follicular lymphoma.

Follicular lymphoma is a diverse disease, both biologically and clinically. Patients may present with indolent, asymptomatic disease or more aggressive, symptomatic disease with high tumor burden.

Table 2. Distinction between atypical lymphoid ... Distinction between atypical lymphoid proliferations with follicular pattern and follicular lymphoma. Atypical lymphoid proliferations with ...

What’s the next step for this patient with a 4-year history of low-grade follicular lymphoma and who now has worsening lymphadenopathy and needs a nap at the end of every work day? Share on ...

This pair of posters presented at the 66th American Society of Hematology Annual Meeting & Exposition provides updates on ...

The new use is the third for Kymriah (tisagenlecleucel) in the EU and offers patients with grade 1, 2 and 3A follicular lymphoma that has returned after two or more prior treatments a new ...

Lady Mendelsohn is Facebook's vice-president for Europe, the Middle East and Africa A British Facebook executive has revealed she has a form of blood cancer called follicular lymphoma. Writing in ...

5 “PET-CT to evaluate response to treatment in patients with follicular lymphoma has been increasingly used by clinicians in the last 2 to 3 years, and clinical trials designed since these data ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...